| Modulating glycolysis to improve cancer therapy C Chelakkot, VS Chelakkot, Y Shin, K Song International Journal of Molecular Sciences 24 (3), 2606, 2023 | 153 | 2023 |
| Enhancement of Cancer-Specific Protoporphyrin IX Fluorescence by Targeting Oncogenic Ras/MEK Pathway E Yoshioka, VS Chelakkot, M Licursi, SG Rutihinda, J Som, L Derwish, ... Theranostics 8 (8), 2134-2146, 2018 | 62 | 2018 |
| Mesenchymal stromal cell secretome up-regulates 47 kDa CXCR4 expression, and induce invasiveness in neuroblastoma cell lines V Shankar, H Hori, K Kihira, Q Lei, H Toyoda, S Iwamoto, Y Komada PloS one 10 (3), e0120069, 2015 | 27 | 2015 |
| Anti-tumor effect of AZD8055 against neuroblastoma cells in vitro and in vivo DQ Xu, H Toyoda, XJ Yuan, L Qi, VS Chelakkot, M Morimoto, R Hanaki, ... Experimental cell research 365 (2), 177-184, 2018 | 26 | 2018 |
| MEK reduces cancer-specific PpIX accumulation through the RSK-ABCB1 and HIF-1α-FECH axes VS Chelakkot, K Liu, E Yoshioka, S Saha, D Xu, M Licursi, A Dorward, ... Scientific reports 10 (1), 22124, 2020 | 24 | 2020 |
| Systemic MEK inhibition enhances the efficacy of 5-aminolevulinic acid-photodynamic therapy VS Chelakkot, J Som, E Yoshioka, CP Rice, SG Rutihinda, K Hirasawa British journal of cancer 121 (9), 758-767, 2019 | 24 | 2019 |
| Heterogeneity of neuroblastoma cell lines in insulin‐like growth factor 1 receptor/Akt pathway‐mediated cell proliferative responses L Qi, H Toyoda, V Shankar, N Sakurai, K Amano, K Kihira, T Iwasa, ... Cancer Science 104 (9), 1162-1171, 2013 | 18 | 2013 |
| Close interaction with bone marrow mesenchymal stromal cells induces the development of cancer stem cell-like immunophenotype in B cell precursor acute lymphoblastic leukemia cells HH Kentaro Kihira, Vipin Shankar Chelakkot, Hiroki Kainuma, Yosuke Okumura ... International Journal of Hematology, 2020 | 14 | 2020 |
| DNA-dependent protein kinase: Epigenetic alterations and the role in genomic stability of cancer VC George, SA Ansari, VS Chelakkot, AL Chelakkot, C Chelakkot, ... Mutation Research/Reviews in Mutation Research 780, 92-105, 2019 | 13 | 2019 |
| MC1R signaling through the cAMP-CREB/ATF-1 and ERK-NFκB pathways accelerates G1/S transition promoting breast cancer progression VS Chelakkot, K Thomas, T Romigh, A Fong, L Li, S Ronen, S Chen, ... NPJ precision oncology 7 (1), 85, 2023 | 10 | 2023 |
| Inflammatory cell death induced by 5-aminolevulinic acid-photodynamic therapy initiates anticancer immunity L Wang, VS Chelakkot, N Newhook, S Tucker, K Hirasawa Frontiers in Oncology 13, 1156763, 2023 | 4 | 2023 |
| Cancer stem cell populations are resistant to 5-aminolevulinic acid-photodynamic therapy (5-ALA-PDT) CPJ Rice, VS Chelakkot, NT Conohan, K Hirasawa Scientific Reports 15 (1), 4367, 2025 | | 2025 |
| Mouse Tail‐Skin Dissociation and Preparation of Live Single‐Cell Suspension for Downstream Analysis of Melanocytes VS Chelakkot, K Thomas, L Hussein, T Romigh, Y Ni, J Arbesman Pigment Cell & Melanoma Research 38 (1), 1-8, 2025 | | 2025 |
| LB1052 Preparing single-cell suspension from mouse tail-skin for downstream single-cell RNA sequencing analysis of the melanocyte niche V Chelakkot, K Thomas, Y Ni, J Arbesman Journal of Investigative Dermatology 144 (8), S187, 2024 | | 2024 |
| Enhancing intensity of tumor-specific fluorescence by MEK inhibition in brain tumor models S Saha Memorial University of Newfoundland, 2022 | | 2022 |
| Knock Out of Cell Death Pathway Components Results in Differential Caspase Expression in Response to HCV Infection HL Wallace, L Wang, C Davidson, V Chelakkot, M Grant, J Pezacki, ... Proceedings 50 (1), 144, 2020 | | 2020 |
| Promotion of in vivo 5-aminolevulinic acid-photodynamic therapy efficacy by MEK inhibition J Som Memorial University of Newfoundland, 2020 | | 2020 |
| Annual Meeting of the Canadian Association for the Study of the Liver (CASL), the Canadian Network on Hepatitis C (CANHEPC) and the Canadian Association of Hepatology Nurses … Canadian Task Force, Y Ariumi, V Pene, T Saito, CJ Schweitzer, L Zhao, ... Canadian Liver Journal 2 (2), 3-135, 2019 | | 2019 |
| PARP1 Inhibitors D Xu, H Toyoda, X Yuan, L Qi, VS Chelakkot, M Morimoto, R Hanaki, ... | | 2018 |
| 47 kda CXCR4: A marker for highly invasive neuroblastoma V Shankar, L Qi, K Kihira, Y Komada, H Hori Cancer Research 74 (19_Supplement), 41-41, 2014 | | 2014 |
Ken HirasawaProfessorVerified email at mun.ca